ClinicalTrials.Veeva

Find clinical trials for Multiple Sclerosis (MS) in New Haven, CT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Sclerosis
Multiple Sclerosis
Relapsing-Remitting Multiple Sclerosis
Chronic Progressive Multiple Sclerosis
Amyotrophic Lateral Sclerosis
Motor Neuron Disease
Muscle Spasticity

Multiple Sclerosis (MS) trials near New Haven, CT, USA:

A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous RO7121932 in Participants With Multiple Sclerosis.

purpose of the study is to evaluate the safety and tolerability of single ascending intravenous (IV) doses of RO7121932 in participants with multiple...

Enrolling
Multiple Sclerosis
Drug: RO7121932

Phase 1

Roche
Roche

New Haven, Connecticut, United States and 23 other locations

To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...

Enrolling
Multiple Sclerosis
Drug: Placebo capsule
Drug: Fingolimod

Phase 3

Novartis
Novartis

Stony Brook, New York, United States and 107 other locations

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...

Enrolling
Relapsing Multiple Sclerosis
Drug: Teriflunomide
Drug: Remibrutinib

Phase 3

Novartis
Novartis

Patchogue, New York, United States and 225 other locations

The primary objectives are to investigate the safety and tolerability of BIIB091 monotherapy in participants with relapsing multiple sclerosis...

Enrolling
Relapsing Forms of Multiple Sclerosis
Drug: BIIB091
Drug: DRF

Phase 2

Biogen
Biogen

Patchogue, New York, United States and 70 other locations

The purpose of this study is to evaluate the safety, tolerability, efficacy, and drug levels of CC-97540 in participants with Relapsing Forms of Multiple...

Enrolling
Multiple Sclerosis
Drug: Cyclophosphamide
Drug: CC-97540

Phase 1

Juno Therapeutics

New Haven, Connecticut, United States and 34 other locations

for the overall conduct of the study at the site, confirmation of subject eligibility, routine study subject clinical management including for MS...

Active, not recruiting
Multiple Sclerosis
Drug: RPC-1063

Phase 3

Celgene
Celgene

East Setauket, New York, United States and 60 other locations

This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sc...

Active, not recruiting
Progressive Multiple Sclerosis (PMS)
Drug: Ocrelizumab

Phase 3

Roche
Roche

New Haven, Connecticut, United States and 125 other locations

It is an open label study to evaluate safety, tolerability and brain microglia response in participants with ALS following multiple doses of...

Active, not recruiting
Amyotrophic Lateral Sclerosis
Drug: BLZ945

Phase 2

Novartis
Novartis

New Haven, Connecticut, United States and 8 other locations

Phase 2/3, randomized, double-blind, placebo-controlled, single-treatment, multicenter trial assessing the efficacy and safety of MYOBLOC for the tre...

Active, not recruiting
Multiple Sclerosis
Cerebrovascular Accident
Drug: Phase 3; MYOBLOC
Drug: Phase 2; Placebo

Phase 2, Phase 3

Supernus Pharmaceuticals
Supernus Pharmaceuticals

Stamford, Connecticut, United States of America and 8 other locations

This is a human clinical study involving the isolation of autologous bone marrow derived stem cells (BMSC) and transfer to the vascular system and in...

Enrolling
MSA - Multiple System Atrophy
Amyotrophic Lateral Sclerosis
Procedure: Intravenous and Intranasal BMSC
MD Stem Cells

Westport, Connecticut, United States and 2 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems